Boston Scientific reports initial data from ACURATE neo2 system study
Boston Scientific has reported the initial data from the ACURATE neo2 Aortic Valve System study evaluating safety and success.
Stay updated with breaking news from Valve System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston Scientific has reported the initial data from the ACURATE neo2 Aortic Valve System study evaluating safety and success.
WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) said that post-market study data reinforced clinical procedural success and safety of the ACURATE neo2 Aortic Valve System.The ACURATE neo2
MARLBOROUGH, Mass. , Nov. 27, 2022 / / -- Boston Scientific Corporation (NYSE:BSX) has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2 TM Aortic Valve System.
/PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study...
MARLBOROUGH, Mass., Nov. 27, 2022 /PRNewswire/ -- Boston Scientific Corporation has announced the first results from the ACURATE neo2 Post Market Clinical Follow-up study evaluating the...